NCT07717437Recruiting
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
Summary
The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clinical/imaging parameters, clinical outcomes, and safety for patients undergoing PVE/HVE.
Inclusion criteria
• Patients who have undergone PVE/HVE or technical variations on this procedure • 18 Years and older • Men and women
Exclusion criteria
Contacts
The trial team's contact details are shown on request.
See the official trial record- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Countries
- Switzerland, Germany, Austria, United States, Australia, Belgium, Canada, Netherlands, New Zealand, Norway, Spain, Sweden, United Kingdom
- Sponsor
- Maastricht University Medical Center(Other)
- Protocol no.
- 2021-2578
- Conditions
- Liver Cancer, Liver Metastases
- Interventions
- —
Locations · 30
- Zurich, SwitzerlandKlinik HirslandenRecruiting at this site
- Aachen, GermanyUniversity Hospital Aachen (Uniklinik RWTH Aachen)Recruiting at this site
- Saarbrücken, GermanyKlinikum SaarbrückenRecruiting at this site
- Halle, GermanyUniversitätsklinikum HalleRecruiting at this site
- Vienna, AustriaMedUni WienRecruiting at this site
- Vienna, AustriaSocial Center South (Klinik Favoriten)Recruiting at this site
- Chicago, United StatesRush University Medical CenterRecruiting at this site
- Rochester, United StatesMayo ClinicRecruiting at this site
- Cleveland, United StatesCleveland ClinicRecruiting at this site
- Clayton, AustraliaMonash Medical CentreRecruiting at this site
- Edegem, BelgiumUZ AntwerpenRecruiting at this site
- Anderlecht, BelgiumErasmus HospitalRecruiting at this site
- Liège, BelgiumCHU de LiègeRecruiting at this site
- Ghent, BelgiumUZ GentRecruiting at this site
- Hamilton, CanadaJuravinski Hospital and Cancer CentreRecruiting at this site
- Ottawa, CanadaThe Ottawa HospitalRecruiting at this site
- Montreal, CanadaMcGill University Health CentreRecruiting at this site
- Maastricht, NetherlandsMUMC+Recruiting at this site
- Amsterdam, NetherlandsAmsterdam UMCRecruiting at this site
- Groningen, NetherlandsUniversitair Medisch Centrum GroningenRecruiting at this site
- Leiden, NetherlandsLeids Universitair Medisch CentrumRecruiting at this site
- Grafton, New ZealandAuckland City HospitalRecruiting at this site
- Oslo, NorwayOslo University HospitalRecruiting at this site
- Badalona, SpainHospital Universitari Germans Trias i PujolRecruiting at this site
- Barcelona, SpainVall d'Hebron University HospitalRecruiting at this site
- Stockholm, SwedenKarolinska University HospitalRecruiting at this site
- Linköping, SwedenUniversity Hospital LinköpingRecruiting at this site
- Liverpool, United KingdomAintree University HospitalRecruiting at this site
- Newcastle upon Tyne, United KingdomNewcastle upon Tyne HospitalsRecruiting at this site
- Birmingham, United KingdomQueen Elizabeth HospitalRecruiting at this site
In total, worldwide, 30 of the 31 sites listed in the registry are recruiting; the other one is not currently recruiting.
Site status per the ClinicalTrials.gov registry (last update posted: July 21, 2026).
This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.
See also
Other versions
These results are indicative and do not replace medical advice — discuss them with your doctor.